#1 Clinical Trials Search in Europe

Fondaparinux Sodium

Fondaparinux Sodium, also known by its brand name Arixtra, is a medication used to prevent and treat blood clots. This article explores various clinical trials investigating the use of Fondaparinux Sodium in different patient populations and medical conditions. These trials aim to determine the drug’s effectiveness, safety, and optimal dosing in preventing venous thromboembolism (VTE) and treating related conditions.

Table of Contents

What is Fondaparinux?

Fondaparinux Sodium, also known by its brand name Arixtra, is a medication used to prevent and treat blood clots[1]. It belongs to a class of drugs called anticoagulants, which are commonly referred to as “blood thinners.” However, it’s important to note that these medications don’t actually thin your blood; instead, they help prevent blood clots from forming or growing larger.

Fondaparinux is a synthetic compound that represents the active portion of the natural heparin molecule[2]. It’s considered a newer and highly effective anticoagulant compared to some older medications in this category.

Conditions Treated with Fondaparinux

Fondaparinux is primarily used to prevent and treat several conditions related to blood clots, including:

  • Deep Vein Thrombosis (DVT): This is a condition where blood clots form in the deep veins, usually in the legs[1].
  • Pulmonary Embolism (PE): This occurs when a blood clot travels to the lungs, potentially causing a life-threatening situation[1].
  • Venous Thromboembolism (VTE): This term encompasses both DVT and PE[3].

Fondaparinux is often used to prevent these conditions in patients who are at high risk, such as those undergoing certain types of surgery or those with limited mobility[4][5].

How Fondaparinux Works

Fondaparinux works by binding to a substance in your blood called antithrombin III. This interaction enhances the body’s natural ability to inactivate Factor Xa, which is a key component in the blood clotting process[6]. By inhibiting Factor Xa, fondaparinux reduces the formation of thrombin (another crucial factor in blood clotting) and ultimately prevents blood clots from forming.

How Fondaparinux is Administered

Fondaparinux is typically administered as a subcutaneous injection, which means it’s injected just under the skin. The dosage and duration of treatment can vary depending on the specific condition being treated and individual patient factors:

  • For preventing blood clots after surgery, a common dosage is 2.5 mg once daily, usually starting 6-8 hours after the operation[7].
  • For treating existing blood clots, higher doses may be used. For instance, patients weighing 100 kg or more might receive 10 mg daily[3].
  • The duration of treatment can range from a few days to several weeks, depending on the patient’s condition and risk factors[7].

Usage in Various Surgeries

Fondaparinux is commonly used to prevent blood clots in patients undergoing various types of surgeries, including:

  • Orthopedic surgeries (such as hip or knee replacements)[1]
  • Abdominal surgeries[4]
  • Urological, obstetric, and gynecological surgeries[4]
  • General surgeries of the lower limb[5]

In these cases, fondaparinux helps reduce the risk of blood clots that can occur due to reduced mobility during and after surgery.

Use in Special Populations

Research has been conducted to understand how fondaparinux works in specific patient groups:

  • Obese patients: Studies have looked at the appropriate dosing for patients with high body weight or Body Mass Index (BMI)[1].
  • Patients with kidney problems: Fondaparinux has been studied as an anticoagulant for patients undergoing dialysis due to acute kidney failure[2].
  • Cancer patients: Some research has explored the use of fondaparinux in patients with certain types of cancer, such as ovarian cancer[6].

Safety and Side Effects

Like all medications, fondaparinux can have side effects. The most significant risk associated with any anticoagulant is bleeding. Patients taking fondaparinux should be monitored for signs of unusual bleeding or bruising[8].

Common side effects may include:

  • Bleeding or bruising at the injection site
  • Mild pain or irritation at the injection site
  • Low red blood cell count (anemia)

More serious side effects, which require immediate medical attention, can include:

  • Severe or uncontrolled bleeding
  • Signs of blood clots (such as sudden shortness of breath, chest pain, or swelling and warmth in a leg)
  • Unusual bruising or bleeding from gums, nose, or in urine or stools

Ongoing Research

Researchers continue to study fondaparinux to better understand its effects and potential uses. Some areas of ongoing research include:

  • Its effectiveness compared to other anticoagulants in various clinical situations[2]
  • Its potential role in cancer treatment, beyond just preventing blood clots[6]
  • Optimal dosing strategies for different patient populations[1]

As with any medication, patients should always consult with their healthcare provider about the potential benefits and risks of fondaparinux for their specific situation.

Aspect Details
Primary Uses Prevention and treatment of venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE)
Administration Subcutaneous injection, typically once daily
Patient Populations Studied Morbidly obese patients, patients undergoing abdominal or gynecologic surgery, patients with acute kidney failure
Key Research Areas Optimal dosing for obese patients, efficacy in preventing post-surgical VTE, use in continuous dialysis, extended prophylaxis in cancer patients
Safety Monitoring Adverse events, particularly bleeding-related complications
Potential Advantages Longer half-life compared to some other anticoagulants, potential for improved efficacy in VTE prevention

FAQ

  • What is Fondaparinux Sodium used for? Fondaparinux Sodium is primarily used to prevent and treat blood clots, particularly in conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). It's often used in patients undergoing surgery or those at high risk of developing blood clots.
  • How is Fondaparinux Sodium administered? Fondaparinux Sodium is typically administered as a subcutaneous injection (under the skin). The dosage and duration of treatment may vary depending on the patient's condition, weight, and other factors.
  • Are there any special considerations for using Fondaparinux Sodium in obese patients? Yes, some clinical trials are specifically investigating the appropriate dosage of Fondaparinux Sodium for morbidly obese patients. This is important because the drug's effectiveness and safety may be affected by a patient's body weight.
  • Can Fondaparinux Sodium be used in patients with kidney problems? There is ongoing research to assess the safety and efficacy of Fondaparinux Sodium in patients with acute kidney failure who require continuous dialysis. However, patients with kidney problems should always consult their doctor before using this medication.
  • Are there any potential side effects of Fondaparinux Sodium? Like all medications, Fondaparinux Sodium can have side effects. The most common concern is bleeding. Clinical trials are monitoring for adverse events, including serious adverse events and hemorrhagic (bleeding-related) adverse events.

Ongoing Clinical Trials on Fondaparinux Sodium

  • Study Comparing Aspirin Alone to Aspirin and Fondaparinux in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI)

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on the Best Antithrombotic Therapy for Patients with Acute Venous Thromboembolism Using Tinzaparin Sodium and Drug Combination

    Recruiting

    3 1 1 1
    Investigated drugs:
    France

Glossary

  • Venous Thromboembolism (VTE): A condition where blood clots form in the veins, typically in the legs (deep vein thrombosis) or lungs (pulmonary embolism).
  • Deep Vein Thrombosis (DVT): A blood clot that forms in a deep vein, usually in the leg.
  • Pulmonary Embolism (PE): A blockage in one of the pulmonary arteries in your lungs, often caused by blood clots that travel from the legs or other parts of the body.
  • Anticoagulant: A type of medication that helps prevent blood clots from forming or growing larger.
  • Subcutaneous Injection: An injection given into the fatty tissue just beneath the skin.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Body Mass Index (BMI): A measure that uses your height and weight to work out if your weight is healthy.
  • Morbidly Obese: A term used to describe people who are very overweight, typically with a BMI of 40 or higher.
  • Hemorrhagic: Relating to or characterized by bleeding or blood flow.
  • Prophylaxis: Preventive treatment or measures taken to prevent a disease or condition.

References

  1. https://clinicaltrials.gov/study/NCT00436787
  2. https://clinicaltrials.gov/study/NCT00256100
  3. https://clinicaltrials.gov/study/NCT01428544
  4. https://clinicaltrials.gov/study/NCT01390883
  5. https://clinicaltrials.gov/study/NCT01390896
  6. https://clinicaltrials.gov/study/NCT00659399
  7. https://clinicaltrials.gov/study/NCT00381888
  8. https://clinicaltrials.gov/study/NCT01428531